Alterity Therapeutics (ATHE) Current Assets (2009 - 2025)
Alterity Therapeutics (ATHE) posted quarterly Current Assets of $37.3 million for Q4 2025, up 446.92% year-over-year from $6.8 million in Q4 2024, and up 27.0% quarter-over-quarter from $29.4 million in Q2 2025.
Alterity Therapeutics (ATHE) Current Assets (2009 - 2025) Analysis & Trends
Alterity Therapeutics' Current Assets history runs 17 years deep, the most recent figure standing at $37.3 million for Q4 2025.
- In Q4 2025, Current Assets rose 446.92% year-over-year to $37.3 million; the TTM figure through Dec 2025 stood at $37.3 million (up 446.92% YoY), while the FY2025 annual figure was $29.4 million, up 134.16% from the prior year.
- Current Assets for Q4 2025 stood at $37.3 million, up from $29.4 million in the prior quarter.
- The five-year high for Current Assets was $37.3 million in Q4 2025, with the low at $270487.7 in Q2 2023.
- The 5-year median for Current Assets is $23.8 million (2021), against an average of $21.0 million.
- The sharpest annual moves came in 2023 and 2024: Current Assets sank 99.08% in 2023, then jumped 4538.2% in 2024.
- Alterity Therapeutics' Current Assets stood at $32.7 million in 2021, then slumped by 33.24% to $21.8 million in 2022, then plunged by 34.38% to $14.3 million in 2023, then sank by 52.35% to $6.8 million in 2024, then soared by 446.92% to $37.3 million in 2025.
- Business Quant data shows ATHE's Current Assets at $37.3 million in Q4 2025, $29.4 million in Q2 2025, and $6.8 million in Q4 2024.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.25 Bn | 131.40 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 86.04 Bn | 78.05 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 65.43 Bn | 60.25 Bn | 1.37 Bn | 8.07 Bn |
| 4 | Moderna | 58.26 Bn | 53.13 Bn | 52.00 Mn | 5.82 Bn |
| 5 | BeOne Medicines | 42.10 Bn | 37.00 Bn | 1.53 Bn | 7.22 Bn |
| 6 | Alnylam Pharmaceuticals | 31.61 Bn | 28.31 Bn | 992.69 Mn | 4.62 Bn |
| 7 | BioNTech SE | 28.03 Bn | 9.63 Bn | 668.28 Mn | 18.80 Bn |
| 8 | Insmed | 27.49 Bn | 26.33 Bn | 358.27 Mn | 1.63 Bn |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | 1.76 Bn |
| 10 | Alterity Therapeutics | 49.04 Mn | 16.74 Mn | - | 37.31 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 37.31 Mn |
| Jun 30, 2025 | 29.38 Mn |
| Dec 31, 2024 | 6.82 Mn |
| Jun 30, 2024 | 12.55 Mn |
| Dec 31, 2023 | 14.32 Mn |
| Jun 30, 2023 | 270,487.73 |
| Dec 31, 2022 | 21.82 Mn |
| Jun 30, 2022 | 29.47 Mn |
| Dec 31, 2021 | 32.68 Mn |
| Jun 30, 2021 | 25.79 Mn |
| Dec 31, 2020 | 27.31 Mn |
| Jun 30, 2020 | 6.45 Mn |
| Dec 31, 2019 | 9.82 Mn |
| Jun 30, 2019 | 13.91 Mn |
| Dec 31, 2018 | 10,104.96 |
| Jun 30, 2018 | 14.12 Mn |
| Dec 31, 2017 | 16.85 Mn |
| Jun 30, 2017 | 18,968.14 |
| Dec 31, 2016 | 22.75 Mn |
| Jun 30, 2016 | 25,131.61 |